Edwards Lifesciences Corporation (EW) fundamentals score
Edwards Lifesciences Corporation is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence, and meaningful partnerships with clinicians and healthcare stakeholders, its employees are inspired by its patient-focused culture to deliver life-changing innovations to those who need them most.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Healthcare · Listed on NYSE
Overall: 6.6 out of 10, Good long-term fundamentals
- Growth: 4.8/10
- Profitability: 6.8/10
- Financial health: 8.9/10
- Earnings quality: 9.3/10
- Valuation: 3.8/10
Scores are calculated from Edwards Lifesciences Corporation’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10